BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 679460)

  • 1. Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator).
    Fogt EJ; Dodd LM; Jenning EM; Clemens AH
    Clin Chem; 1978 Aug; 24(8):1366-72. PubMed ID: 679460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the BIOSTATOR systems glucose analyzer.
    Fogt EJ; Dodd LM; Eddy AR; Jenning E; Clemens AH
    Horm Metab Res Suppl; 1979; (8):18-24. PubMed ID: 295037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feedback control dynamics for glucose controlled insulin infusion system.
    Clemens AH
    Med Prog Technol; 1979 Jun; 6(3):91-8. PubMed ID: 481365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).
    Clemens AH; Chang PH; Myers RW
    Horm Metab Res; 1977; Suppl 7():23-33. PubMed ID: 873440
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
    Ratzmann KP; Jutzi E; Albrecht G
    Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An artificial betacell: assessment of the glucose analyser, infusion system and optimization of constants for the algorithms.
    Christiansen JS; Svendsen PA; Søegaard U; Frandsen M; Mathiesen E; Winther K; Deckert T
    Scand J Clin Lab Invest; 1981 Nov; 41(7):647-54. PubMed ID: 7041239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
    Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
    Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the co-immobilized hexokinase/glucose-6-phosphate dehydrogenase method for glucose, as adapted to the Technicon SMAC.
    Garber CC; Feldbruegge D; Miller RC; Carey RN
    Clin Chem; 1978 Jul; 24(7):1186-90. PubMed ID: 657501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portable continuous blood glucose analyzer.
    Hakanson H
    Methods Enzymol; 1988; 137():319-26. PubMed ID: 3287093
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic determination of serum glucose by use of the hexokinase/glucose-6-phosphate dehydrogenase method.
    Deeg R; Kraemer W; Ziegenhorn J
    J Clin Chem Clin Biochem; 1980 Jan; 18(1):49-52. PubMed ID: 7359090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma glucose measurement with the Yellow Springs Glucose Analyzer.
    Chua KS; Tan IK
    Clin Chem; 1978 Jan; 24(1):150-2. PubMed ID: 618647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid intravenous sodium acetoacetate infusion in man. Metabolic and kinetic responses.
    Owen OE; Reichard GA; Markus H; Boden G; Mozzoli MA; Shuman CR
    J Clin Invest; 1973 Oct; 52(10):2606-16. PubMed ID: 4729054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
    Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
    Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
    J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multichannel electrochemical centrifugal analyzer.
    Cho HK; Lee YH; Couch RA; Jagadeesh JM; Olson CL
    Clin Chem; 1982 Sep; 28(9):1956-61. PubMed ID: 7127810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory comparison of enzymatic methods for serum glucose determination.
    Gochman N; Ryan WT; Sterling RE; Widdowson GM
    Clin Chem; 1975 Mar; 21(3):356-61. PubMed ID: 1112045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose controlled insulin infusion system (Biostator) application during surgery for a presumed pancreatic microinsulinoma.
    Massi-Benedetti M; Noy G; Johnston ID; Worth R; Alberti KG
    Diabete Metab; 1981 Mar; 7(1):41-4. PubMed ID: 6263727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.